查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526928

COVID-19 唾液篩檢測試潛力全球市場報告 2024 年

COVID-19 Saliva Screening Test Potential Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

COVID-19唾液篩檢測試潛在市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以9.6%的複合年成長率成長至56.4億美元。預測期內的預期成長是由於篩檢計畫的整合、監管推動、快速照護現場COVID-19 檢測需求激增、人口成長以及電子商務激增。預測期內預期的顯著趨勢包括在非醫療保健環境中的採用增加、與數位健康平台的整合、下一代技術的出現、技術進步、策略聯盟等。

醫療保健支出的增加預計將推動 COVID-19 唾液篩檢測試市場的未來擴張。醫療保健支出包括與醫療保健相關的商品和服務的總支出，例如處方藥、住院、看醫生、醫療設備和公共衛生措施。有幾個因素導致醫療保健支出增加，包括微創手術、先進的診斷技術、新藥研發的活性化、醫療保健服務的使用增加以及特殊藥物的使用。增加醫療保健支出可以提供所需的資源和支持，以最大限度地發揮 COVID-19 唾液篩檢測試的潛力，從而支持更有效的大流行管理，並提高其可以促進良好的公共衛生結果。例如，2023年5月，英國統計機構國家統計局報告稱，英國醫療保健支出實際成長9.7%，名目增加9.4%。 2021年，英國醫療保健支出總額達3,672.5億美元（2,807億日圓），其中藥品支出達518.4億美元（396億日圓）。此外，2021 年預防保健支出飆升至 459.3 億美元（351 億英鎊），是與前一年同期比較的四倍多。因此，不斷成長的醫療保健支出正在推動 COVID-19 唾液篩檢測試潛在市場的成長。

潛在的 COVID-19 唾液篩檢測試市場的主要參與者致力於開發創新舉措，例如 COVID-19 唾液測試項目，以擴大產品系列涵蓋更廣泛的客戶群。 COVID-19 唾液檢測計畫是指使用唾液樣本而不是更具侵入性的鼻咽和鼻拭子來檢測 SARS-CoV-2（導致 COVID-19 的病毒）的措施和系統。例如，美國醫療保健網路西奈山健康系統於 2021 年 4 月推出了西奈山 COVID-19 PCR 唾液檢測計劃，該計劃提供快速、非侵入性且準確的檢測。該計劃旨在提供快速、準確的結果，讓個人能夠自信地恢復面對面的工作和休閒活動。該程式的一個關鍵特點是其擴充性，目標是每天處理多達 100,000 個測試，並使測試廣泛可用。其高效性體現在大多數測試能夠在 24 小時內提供結果，展示了其快速反應能力。此外，該計劃優先考慮提供兒童友好且舒適的測試選項，以幫助兒童安全地返回面對面的學習和活動。該舉措強調了檢測在遏制 COVID-19 感染方面的重要性，並支持重新開放階段的社區福祉。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球 COVID-19 唾液篩檢測試潛在市場：促進因素和限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球 COVID-19 唾液篩檢測試潛在市場表現：規模和成長，2018-2023 年
  • 全球 COVID-19 唾液篩檢測試潛在市場預測：規模和成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球 COVID-19 唾液篩檢測試潛在市場：按地點、實際和預測，2018-2023、2023-2028、2033
  • 觀光站
  • 運動場
  • 娛樂場所
  • 企業園區環境
  • 大學和學院
  • 工廠
  • 其他地點
  • 全球COVID-19唾液篩檢測試潛在市場：依技術、效能和預測分類，2018-2023年、2023-2028、2033年
  • 螢光標記抗原
  • RT-PCR
  • 更脆的Cas9
  • 全球COVID-19唾液篩檢測試潛在市場：依測試模式、實際與預測，2018-2023年、2023-2028、2033年
  • 強化檢查
  • 分散式測試

第 7 章 區域/國家分析

  • 全球COVID-19唾液篩檢測試潛在市場：按地區、表現和預測，2018-2023年、2023-2028年、2033年
  • 全球COVID-19唾液篩檢測試潛在市場：按國家、表現和預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • COVID-19唾液篩檢測試潛在市場：競爭格局
  • COVID-19 唾液篩檢測試潛在市場：公司簡介
    • Roche Diagnostics Corporation
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Danaher Corporation

第31章 其他大型創新企業

  • University of North Carolina at Chapel Hill
  • Hologic Inc.
  • Beaumont Health
  • PerkinElmer Inc.
  • Quidel Corporation
  • University of Illinois at Urbana-Champaign
  • Cepheid
  • Seegene Inc.
  • ARUP Laboratories
  • Vatic Health Limited
  • Ambry Genetics Corporation
  • LumiraDx Ltd.
  • Yale School of Public Health
  • Gravity Diagnostics
  • Psomagen Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18577

The potential of saliva-based COVID-19 screening tests pertains to the possible benefits and capabilities they offer in comparison to conventional methods such as nasopharyngeal or oropharyngeal swab tests for detecting the SARS-CoV-2 virus, which causes COVID-19. This potential encompasses enhancements in testing accessibility, patient acceptance, cost-effectiveness, and safety, while also facilitating the adoption of new testing strategies and approaches for better management of the pandemic.

Key locations where the potential of COVID-19 saliva screening tests is prominent include travel stations, sports arenas, entertainment venues, corporate campuses, universities and colleges, factories, and similar settings. Travel stations are specifically designated areas within transportation hubs where individuals can undergo COVID-19 saliva screening tests before commencing their journeys. These tests utilize various technologies such as fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9, with testing conducted through centralized or decentralized approaches.

The COVID-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides COVID-19 saliva screening test potential market statistics, including COVID-19 saliva screening test potential industry global market size, regional shares, competitors with a COVID-19 saliva screening test potential market share, detailed COVID-19 saliva screening test potential market segments, market trends, and opportunities, and any further data you may need to thrive in the COVID-19 saliva screening test potential industry. This COVID-19 saliva screening test potential market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.57 billion in 2023 to $3.90 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The increase observed in the historic period can be credited to the potential for home testing, an unparalleled demand for diagnostic testing, heightened public awareness, and investments in research and development.

The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The rise projected for the forecast period can be ascribed to integration with screening programs, regulatory backing, the burgeoning requirement for rapid, point-of-care COVID-19 tests, population growth, and the surge of e-commerce. Noteworthy trends anticipated in the forecast period encompass heightened adoption in non-healthcare environments, incorporation with digital health platforms, the advent of next-generation technologies, technological progressions, and strategic collaborations.

The uptick in healthcare expenditure is projected to drive the expansion of the potential market for COVID-19 saliva screening tests in the future. Healthcare expenditure encompasses the total spending on healthcare-related goods and services, encompassing prescription drugs, hospital stays, doctor visits, medical equipment, and public health initiatives. Several factors contribute to the increase in healthcare expenditure, including minimally invasive surgeries, advanced diagnostic technologies, heightened research and development for new pharmaceuticals, increased utilization of healthcare services, and the use of specialty medications. Elevated healthcare expenditure can furnish the necessary resources and support to harness the full potential of COVID-19 saliva screening tests, thereby aiding more effective pandemic management and fostering better public health outcomes. For example, in May 2023, the Office for National Statistics, a UK-based statistical authority, reported a 9.7% increase in real terms and a 9.4% increase in nominal terms in the UK's healthcare expenditure. The total healthcare expenditure in the UK in 2021 amounted to $367.25 billion (£280.7 billion), with pharmaceutical spending reaching $51.84 billion (£39.6 billion). Additionally, spending on preventative care surged more than fourfold to $45.93 billion (£35.1 billion) in 2021 compared to the previous year. Consequently, the rising healthcare expenditure propels the growth of the COVID-19 saliva screening test potential market.

Key players in the potential market for COVID-19 saliva screening tests are dedicated to developing innovative initiatives, such as COVID-19 saliva testing programs, to broaden their product portfolios and reach a wider customer base. A COVID-19 saliva testing program refers to an initiative or system implemented to detect SARS-CoV-2 (the virus causing COVID-19) using saliva samples instead of more invasive nasopharyngeal or nasal swabs. For instance, in April 2021, Mount Sinai Health System, a US-based healthcare network, introduced the Mount Sinai COVID-19 PCR Saliva Testing program to offer rapid, noninvasive, and accurate testing. This program is tailored to deliver swift and precise results, enabling individuals to confidently resume in-person work and leisure activities. Noteworthy for its scalability, the program aims to process up to 100,000 daily tests, ensuring widespread testing availability. Its efficiency is underscored by the ability to deliver results within 24 hours for most tests, showcasing rapid response capabilities. Furthermore, the program prioritizes providing child-friendly and comfortable testing options to facilitate the safe return to in-person learning and activities. This initiative underscores the significance of testing in curtailing COVID-19 transmission and supports community well-being during the reopening phase.

In June 2021, Hologic Inc., a US-based health technology company, completed the acquisition of Mobidiag Oy for an undisclosed sum. This strategic acquisition empowers Hologic to broaden its footprint in the diagnostics market by harnessing Mobidiag's cutting-edge near-patient molecular diagnostic instruments and tests. Mobidiag Oy, headquartered in Finland, specializes in COVID-19 saliva screening tests.

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 saliva screening test potential market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Saliva Screening Test Potential Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on COVID-19 saliva screening test potential market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for COVID-19 saliva screening test potential ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The COVID-19 saliva screening test potential market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Location: Travel Stations; Sports Arenas; Entertainment Venues; Corporate Campus Environments; Universities And Colleges; Factories; Other Locations
  • 2) By Technology: Fluorescence-Labelled Antigen; RT-PCR; CRISPR-Cas9
  • 3) By Mode of Testing: Centralized Testing; Decentralized Testing
  • Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. COVID-19 Saliva Screening Test Potential Market Characteristics

3. COVID-19 Saliva Screening Test Potential Market Trends And Strategies

4. COVID-19 Saliva Screening Test Potential Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global COVID-19 Saliva Screening Test Potential Market Size and Growth

  • 5.1. Global COVID-19 Saliva Screening Test Potential Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global COVID-19 Saliva Screening Test Potential Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global COVID-19 Saliva Screening Test Potential Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. COVID-19 Saliva Screening Test Potential Market Segmentation

  • 6.1. Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Travel Stations
  • Sports Arenas
  • Entertainment Venues
  • Corporate Campus Environments
  • Universities And Colleges
  • Factories
  • Other Locations
  • 6.2. Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fluorescence-Labelled Antigen
  • RT-PCR
  • CRISPR-Cas9
  • 6.3. Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Centralized Testing
  • Decentralized Testing

7. COVID-19 Saliva Screening Test Potential Market Regional And Country Analysis

  • 7.1. Global COVID-19 Saliva Screening Test Potential Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global COVID-19 Saliva Screening Test Potential Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific COVID-19 Saliva Screening Test Potential Market

  • 8.1. Asia-Pacific COVID-19 Saliva Screening Test Potential Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China COVID-19 Saliva Screening Test Potential Market

  • 9.1. China COVID-19 Saliva Screening Test Potential Market Overview
  • 9.2. China COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India COVID-19 Saliva Screening Test Potential Market

  • 10.1. India COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan COVID-19 Saliva Screening Test Potential Market

  • 11.1. Japan COVID-19 Saliva Screening Test Potential Market Overview
  • 11.2. Japan COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia COVID-19 Saliva Screening Test Potential Market

  • 12.1. Australia COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia COVID-19 Saliva Screening Test Potential Market

  • 13.1. Indonesia COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea COVID-19 Saliva Screening Test Potential Market

  • 14.1. South Korea COVID-19 Saliva Screening Test Potential Market Overview
  • 14.2. South Korea COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe COVID-19 Saliva Screening Test Potential Market

  • 15.1. Western Europe COVID-19 Saliva Screening Test Potential Market Overview
  • 15.2. Western Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK COVID-19 Saliva Screening Test Potential Market

  • 16.1. UK COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany COVID-19 Saliva Screening Test Potential Market

  • 17.1. Germany COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France COVID-19 Saliva Screening Test Potential Market

  • 18.1. France COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy COVID-19 Saliva Screening Test Potential Market

  • 19.1. Italy COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain COVID-19 Saliva Screening Test Potential Market

  • 20.1. Spain COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe COVID-19 Saliva Screening Test Potential Market

  • 21.1. Eastern Europe COVID-19 Saliva Screening Test Potential Market Overview
  • 21.2. Eastern Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia COVID-19 Saliva Screening Test Potential Market

  • 22.1. Russia COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America COVID-19 Saliva Screening Test Potential Market

  • 23.1. North America COVID-19 Saliva Screening Test Potential Market Overview
  • 23.2. North America COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA COVID-19 Saliva Screening Test Potential Market

  • 24.1. USA COVID-19 Saliva Screening Test Potential Market Overview
  • 24.2. USA COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada COVID-19 Saliva Screening Test Potential Market

  • 25.1. Canada COVID-19 Saliva Screening Test Potential Market Overview
  • 25.2. Canada COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America COVID-19 Saliva Screening Test Potential Market

  • 26.1. South America COVID-19 Saliva Screening Test Potential Market Overview
  • 26.2. South America COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil COVID-19 Saliva Screening Test Potential Market

  • 27.1. Brazil COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East COVID-19 Saliva Screening Test Potential Market

  • 28.1. Middle East COVID-19 Saliva Screening Test Potential Market Overview
  • 28.2. Middle East COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa COVID-19 Saliva Screening Test Potential Market

  • 29.1. Africa COVID-19 Saliva Screening Test Potential Market Overview
  • 29.2. Africa COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. COVID-19 Saliva Screening Test Potential Market Competitive Landscape And Company Profiles

  • 30.1. COVID-19 Saliva Screening Test Potential Market Competitive Landscape
  • 30.2. COVID-19 Saliva Screening Test Potential Market Company Profiles
    • 30.2.1. Roche Diagnostics Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. COVID-19 Saliva Screening Test Potential Market Other Major And Innovative Companies

  • 31.1. University of North Carolina at Chapel Hill
  • 31.2. Hologic Inc.
  • 31.3. Beaumont Health
  • 31.4. PerkinElmer Inc.
  • 31.5. Quidel Corporation
  • 31.6. University of Illinois at Urbana-Champaign
  • 31.7. Cepheid
  • 31.8. Seegene Inc.
  • 31.9. ARUP Laboratories
  • 31.10. Vatic Health Limited
  • 31.11. Ambry Genetics Corporation
  • 31.12. LumiraDx Ltd.
  • 31.13. Yale School of Public Health
  • 31.14. Gravity Diagnostics
  • 31.15. Psomagen Inc.

32. Global COVID-19 Saliva Screening Test Potential Market Competitive Benchmarking

33. Global COVID-19 Saliva Screening Test Potential Market Competitive Dashboard

34. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential Market

35. COVID-19 Saliva Screening Test Potential Market Future Outlook and Potential Analysis

  • 35.1 COVID-19 Saliva Screening Test Potential Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 COVID-19 Saliva Screening Test Potential Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 COVID-19 Saliva Screening Test Potential Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer